On the other hand, in coronary artery disease (CAD), the mRNA levels of the antioxidant enzyme NQO1 in PBMCs showed no significant difference as compared to control samples [54], highlighting either a systemic adaptation to the disease or that distinct pathways are activated in a disease/pathology-specific mode. Here, NQO1 is linked to coronary artery disorder.